heptavalent vaccine (Instituto Butantan/Bio-Manguinhos/Fiocruz/Funed)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameheptavalent vaccine (Instituto Butantan/Bio-Manguinhos/Fiocruz/Funed)
Drug Alias NameDTP-HEPB-HIB-IPV-MENC vaccine (Instituto Butantan)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis BPoliomyelitisTetanus +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBio-Manguinhos
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFundação Ezequiel Dias - FunedBio-ManguinhosInstituto Butantan
Active IndicationsN/A
Inactive IndicationsHepatitis BPoliomyelitisTetanus +[7] 

Other Information

ATC CodeN/A
Related LinksN/A